TY - JOUR AU - Kocijancic, D. AU - Leschner, S. AU - Felgner, S. AU - Komoll, R. M. AU - Frahm, M. AU - Pawar, V. AU - Weiss, S. PY - 2017 DA - 2017// TI - Therapeutic benefit of Salmonella attributed to LPS and TNF-alpha is exhaustible and dictated by tumor susceptibility JO - Oncotarget VL - 8 ID - Kocijancic2017 ER - TY - JOUR AU - Ganai, S. AU - Arenas, R. B. AU - Sauer, J. P. AU - Bentley, B. AU - Forbes, N. S. PY - 2011 DA - 2011// TI - In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis JO - Cancer Gene Ther VL - 18 UR - https://doi.org/10.1038/cgt.2011.10 DO - 10.1038/cgt.2011.10 ID - Ganai2011 ER - TY - JOUR AU - Brown, J. M. AU - Wilson, W. R. PY - 2004 DA - 2004// TI - Exploiting tumour hypoxia in cancer treatment JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1367 DO - 10.1038/nrc1367 ID - Brown2004 ER - TY - STD TI - Hoffman RM. (ed.) Bacterial Therapy of Cancer: Methods and Protocols. Methods in Molecular Biology. Volume 1409. Totowa: Humana Press Inc; 2016. p. 1–186. ID - ref4 ER - TY - JOUR AU - McCarthy, E. F. PY - 2006 DA - 2006// TI - The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas JO - Iowa Orthop J VL - 26 ID - McCarthy2006 ER - TY - JOUR AU - Richardson, M. A. AU - Ramirez, T. AU - Russell, N. C. AU - Moye, L. A. PY - 1999 DA - 1999// TI - Coley toxins immunotherapy: a retrospective review JO - Altern Ther Health Med VL - 5 ID - Richardson1999 ER - TY - JOUR AU - Cann, S. A. H. AU - van Netten, J. P. AU - van Netten, C. PY - 2003 DA - 2003// TI - Dr William Coley and tumour regression: a place in history or in the future JO - Postgraduate Medical Journal VL - 79 ID - Cann2003 ER - TY - JOUR AU - Zhao, M. AU - Yang, M. AU - Li, X. M. AU - Jiang, P. AU - Baranov, E. AU - Li, S. AU - Xu, M. AU - Penman, S. AU - Hoffman, R. M. PY - 2005 DA - 2005// TI - Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0408422102 DO - 10.1073/pnas.0408422102 ID - Zhao2005 ER - TY - JOUR AU - Moese, J. R. AU - Moese, G. PY - 1964 DA - 1964// TI - Oncolysis by clostridia. I. Activity of clostridium butyricum (m-55) and other nonpathogenic clostridia against the Ehrlich carcinoma JO - Cancer Res VL - 24 ID - Moese1964 ER - TY - JOUR AU - Roberts, N. J. AU - Zhang, L. AU - Janku, F. AU - Collins, A. AU - Bai, R. Y. AU - Staedtke, V. AU - Rusk, A. W. AU - Tung, D. AU - Miller, M. AU - Roix, J. PY - 2014 DA - 2014// TI - Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3008982 DO - 10.1126/scitranslmed.3008982 ID - Roberts2014 ER - TY - JOUR AU - Kelly, E. AU - Russell, S. J. PY - 2007 DA - 2007// TI - History of oncolytic viruses: genesis to genetic engineering JO - Mol Ther VL - 15 UR - https://doi.org/10.1038/sj.mt.6300108 DO - 10.1038/sj.mt.6300108 ID - Kelly2007 ER - TY - JOUR AU - Miest, T. S. AU - Cattaneo, R. PY - 2014 DA - 2014// TI - New viruses for cancer therapy: meeting clinical needs JO - Nat Rev Microbiol VL - 12 UR - https://doi.org/10.1038/nrmicro3140 DO - 10.1038/nrmicro3140 ID - Miest2014 ER - TY - JOUR AU - d’Herelle, F. H. PY - 1917 DA - 1917// TI - Sur un microbe invisible antagoniste des bacilles dysenteriques JO - C R Hebd Seances Acad Sci Paris VL - 165 ID - d’Herelle1917 ER - TY - JOUR AU - Dock, G. PY - 1904 DA - 1904// TI - The influence of complicating diseases upon leukemia JO - Am J Med Sci VL - 127 UR - https://doi.org/10.1097/00000441-190412740-00001 DO - 10.1097/00000441-190412740-00001 ID - Dock1904 ER - TY - JOUR AU - Pelner, L. AU - Fowler, G. A. AU - Nauts, H. C. PY - 1958 DA - 1958// TI - Effects of concurrent infections and their toxins on the course of leukemia JO - Acta Med Scand Suppl VL - 338 ID - Pelner1958 ER - TY - JOUR AU - Hoster, H. A. AU - Zanes, R. P. AU - Von Haam, E. PY - 1949 DA - 1949// TI - Studies in Hodgkin's syndrome; the association of viral hepatitis and Hodgkin's disease; a preliminary report JO - Cancer Res VL - 9 ID - Hoster1949 ER - TY - JOUR AU - Martuza, R. L. AU - Malick, A. AU - Markert, J. M. AU - Ruffner, K. L. AU - Coen, D. M. PY - 1991 DA - 1991// TI - Experimental therapy of human glioma by means of a genetically engineered virus mutant JO - Science VL - 252 UR - https://doi.org/10.1126/science.1851332 DO - 10.1126/science.1851332 ID - Martuza1991 ER - TY - JOUR AU - Forbes, N. S. PY - 2010 DA - 2010// TI - Engineering the perfect (bacterial) cancer therapy JO - Nature Reviews Cancer VL - 10 UR - https://doi.org/10.1038/nrc2934 DO - 10.1038/nrc2934 ID - Forbes2010 ER - TY - JOUR AU - Felgner, S. AU - Kocijancic, D. AU - Frahm, M. AU - Weiss, S. PY - 2016 DA - 2016// TI - Bacteria in Cancer Therapy: Renaissance of an Old Concept JO - Int J Microbiol VL - 2016 UR - https://doi.org/10.1155/2016/8451728 DO - 10.1155/2016/8451728 ID - Felgner2016 ER - TY - JOUR AU - Andtbacka, R. H. AU - Kaufman, H. L. AU - Collichio, F. AU - Amatruda, T. AU - Senzer, N. AU - Chesney, J. AU - Delman, K. A. AU - Spitler, L. E. AU - Puzanov, I. AU - Agarwala, S. S. PY - 2015 DA - 2015// TI - Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.3377 DO - 10.1200/JCO.2014.58.3377 ID - Andtbacka2015 ER - TY - JOUR AU - Breitbach, C. J. AU - Lichty, B. D. AU - Bell, J. C. PY - 2016 DA - 2016// TI - Oncolytic Viruses: Therapeutics With an Identity Crisis JO - EBioMedicine VL - 9 UR - https://doi.org/10.1016/j.ebiom.2016.06.046 DO - 10.1016/j.ebiom.2016.06.046 ID - Breitbach2016 ER - TY - JOUR AU - Ilkow, C. S. AU - Swift, S. L. AU - Bell, J. C. AU - Diallo, J. S. PY - 2014 DA - 2014// TI - From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer JO - PLoS Pathog VL - 10 UR - https://doi.org/10.1371/journal.ppat.1003836 DO - 10.1371/journal.ppat.1003836 ID - Ilkow2014 ER - TY - JOUR AU - Pol, J. AU - Buque, A. AU - Aranda, F. AU - Bloy, N. AU - Cremer, I. AU - Eggermont, A. AU - Erbs, P. AU - Fucikova, J. AU - Galon, J. AU - Limacher, J. M. PY - 2016 DA - 2016// TI - Trial Watch-Oncolytic viruses and cancer therapy JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2015.1117740 DO - 10.1080/2162402X.2015.1117740 ID - Pol2016 ER - TY - JOUR AU - Dang, L. H. AU - Bettegowda, C. AU - Huso, D. L. AU - Kinzler, K. W. AU - Vogelstein, B. PY - 2001 DA - 2001// TI - Combination bacteriolytic therapy for the treatment of experimental tumors JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.251543698 DO - 10.1073/pnas.251543698 ID - Dang2001 ER - TY - JOUR AU - Ganai, S. AU - Arenas, R. B. AU - Forbes, N. S. PY - 2009 DA - 2009// TI - Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605403 DO - 10.1038/sj.bjc.6605403 ID - Ganai2009 ER - TY - JOUR AU - Agrawal, N. AU - Bettegowda, C. AU - Cheong, I. AU - Geschwind, J. F. AU - Drake, C. G. AU - Hipkiss, E. L. AU - Tatsumi, M. AU - Dang, L. H. AU - Diaz, L. A. AU - Pomper, M. PY - 2004 DA - 2004// TI - Bacteriolytic therapy can generate a potent immune response against experimental tumors JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0406242101 DO - 10.1073/pnas.0406242101 ID - Agrawal2004 ER - TY - JOUR AU - Thamm, D. H. AU - Kurzman, I. D. AU - King, I. AU - Li, Z. AU - Sznol, M. AU - Dubielzig, R. R. AU - Vail, D. M. AU - MacEwen, E. G. PY - 2005 DA - 2005// TI - Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2510 DO - 10.1158/1078-0432.CCR-04-2510 ID - Thamm2005 ER - TY - JOUR AU - Clairmont, C. AU - Lee, K. C. AU - Pike, J. AU - Ittensohn, M. AU - Low, K. B. AU - Pawelek, J. AU - Bermudes, D. AU - Brecher, S. M. AU - Margitich, D. AU - Turnier, J. PY - 2000 DA - 2000// TI - Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium JO - J Infect Dis VL - 181 UR - https://doi.org/10.1086/315497 DO - 10.1086/315497 ID - Clairmont2000 ER - TY - JOUR AU - Diaz, L. A. AU - Cheong, I. AU - Foss, C. A. AU - Zhang, X. AU - Peters, B. A. AU - Agrawal, N. AU - Bettegowda, C. AU - Karim, B. AU - Liu, G. AU - Khan, K. PY - 2005 DA - 2005// TI - Pharmacologic and toxicologic evaluation of C. novyi-NT spores JO - Toxicol Sci VL - 88 UR - https://doi.org/10.1093/toxsci/kfi316 DO - 10.1093/toxsci/kfi316 ID - Diaz2005 ER - TY - JOUR AU - Wood, L. M. AU - Paterson, Y. PY - 2014 DA - 2014// TI - Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy JO - Front Cell Infect Microbiol VL - 4 UR - https://doi.org/10.3389/fcimb.2014.00051 DO - 10.3389/fcimb.2014.00051 ID - Wood2014 ER - TY - JOUR AU - Le, D. T. AU - Wang-Gillam, A. AU - Picozzi, V. AU - Greten, T. F. AU - Crocenzi, T. AU - Springett, G. AU - Morse, M. AU - Zeh, H. AU - Cohen, D. AU - Fine, R. L. PY - 2015 DA - 2015// TI - Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.4244 DO - 10.1200/JCO.2014.57.4244 ID - Le2015 ER - TY - JOUR AU - Miles, B. AU - Safran, H. P. AU - Monk, B. J. PY - 2017 DA - 2017// TI - Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001 JO - Gynecol Oncol Res Pract VL - 4 UR - https://doi.org/10.1186/s40661-017-0047-8 DO - 10.1186/s40661-017-0047-8 ID - Miles2017 ER - TY - JOUR AU - Maciag, P. C. AU - Radulovic, S. AU - Rothman, J. PY - 2009 DA - 2009// TI - The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix JO - Vaccine VL - 27 UR - https://doi.org/10.1016/j.vaccine.2009.04.041 DO - 10.1016/j.vaccine.2009.04.041 ID - Maciag2009 ER - TY - STD TI - Safran H, Leonard KL, Perez K, Vrees M, Klipfel A, Schechter S, Oldenburg N, Roth L, Shah N, Rosati K, et al. Tolerability of ADXS11-001 Lm-LLO Listeria Based Immunotherapy With Mitomycin, Fluorouracil and Radiation for Anal Cancer. Int J Radiat Oncol Biol Phys. 2018;100:1175–78. ID - ref34 ER - TY - JOUR AU - Le, D. T. AU - Brockstedt, D. G. AU - Nir-Paz, R. AU - Hampl, J. AU - Mathur, S. AU - Nemunaitis, J. AU - Sterman, D. H. AU - Hassan, R. AU - Lutz, E. AU - Moyer, B. PY - 2012 DA - 2012// TI - A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2121 DO - 10.1158/1078-0432.CCR-11-2121 ID - Le2012 ER - TY - JOUR AU - Kamat, A. M. AU - Flaig, T. W. AU - Grossman, H. B. AU - Konety, B. AU - Lamm, D. AU - O'Donnell, M. A. AU - Uchio, E. AU - Efstathiou, J. A. AU - Taylor, J. A. PY - 2015 DA - 2015// TI - Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer JO - Nat Rev Urol VL - 12 UR - https://doi.org/10.1038/nrurol.2015.58 DO - 10.1038/nrurol.2015.58 ID - Kamat2015 ER - TY - JOUR AU - Sharma, P. AU - Allison, J. P. PY - 2015 DA - 2015// TI - The future of immune checkpoint therapy JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa8172 DO - 10.1126/science.aaa8172 ID - Sharma2015 ER - TY - JOUR AU - Schildberg, F. A. AU - Klein, S. R. AU - Freeman, G. J. AU - Sharpe, A. H. PY - 2016 DA - 2016// TI - Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.05.002 DO - 10.1016/j.immuni.2016.05.002 ID - Schildberg2016 ER - TY - JOUR AU - Topalian, S. L. AU - Drake, C. G. AU - Pardoll, D. M. PY - 2015 DA - 2015// TI - Immune checkpoint blockade: a common denominator approach to cancer therapy JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.03.001 DO - 10.1016/j.ccell.2015.03.001 ID - Topalian2015 ER - TY - JOUR AU - Zou, W. AU - Wolchok, J. D. AU - Chen, L. PY - 2016 DA - 2016// TI - PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aad7118 DO - 10.1126/scitranslmed.aad7118 ID - Zou2016 ER - TY - JOUR AU - Pitt, J. M. AU - Vetizou, M. AU - Daillere, R. AU - Roberti, M. P. AU - Yamazaki, T. AU - Routy, B. AU - Lepage, P. AU - Boneca, I. G. AU - Chamaillard, M. AU - Kroemer, G. AU - Zitvogel, L. PY - 2016 DA - 2016// TI - Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.06.001 DO - 10.1016/j.immuni.2016.06.001 ID - Pitt2016 ER - TY - JOUR AU - Shin, D. S. AU - Zaretsky, J. M. AU - Escuin-Ordinas, H. AU - Garcia-Diaz, A. AU - Hu-Lieskovan, S. AU - Kalbasi, A. AU - Grasso, C. S. AU - Hugo, W. AU - Sandoval, S. AU - Torrejon, D. Y. PY - 2017 DA - 2017// TI - Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-1223 DO - 10.1158/2159-8290.CD-16-1223 ID - Shin2017 ER - TY - JOUR AU - Myint, Z. W. AU - Goel, G. PY - 2017 DA - 2017// TI - Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0454-7 DO - 10.1186/s13045-017-0454-7 ID - Myint2017 ER - TY - JOUR AU - Murphy, A. G. AU - Kelly, R. J. PY - 2017 DA - 2017// TI - The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer JO - Hematol Oncol Clin North Am VL - 31 UR - https://doi.org/10.1016/j.hoc.2017.01.007 DO - 10.1016/j.hoc.2017.01.007 ID - Murphy2017 ER - TY - JOUR AU - Laccetti, A. L. AU - Subudhi, S. K. PY - 2017 DA - 2017// TI - Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg? JO - Curr Opin Urol VL - 27 UR - https://doi.org/10.1097/MOU.0000000000000433 DO - 10.1097/MOU.0000000000000433 ID - Laccetti2017 ER - TY - JOUR AU - Foley, K. AU - Kim, V. AU - Jaffee, E. AU - Zheng, L. PY - 2016 DA - 2016// TI - Current progress in immunotherapy for pancreatic cancer JO - Cancer Lett VL - 381 UR - https://doi.org/10.1016/j.canlet.2015.12.020 DO - 10.1016/j.canlet.2015.12.020 ID - Foley2016 ER - TY - JOUR AU - Prieto, J. AU - Melero, I. AU - Sangro, B. PY - 2015 DA - 2015// TI - Immunological landscape and immunotherapy of hepatocellular carcinoma JO - Nat Rev Gastroenterol Hepatol VL - 12 UR - https://doi.org/10.1038/nrgastro.2015.173 DO - 10.1038/nrgastro.2015.173 ID - Prieto2015 ER - TY - JOUR AU - Yarchoan, M. AU - Hopkins, A. AU - Jaffee, E. M. PY - 2017 DA - 2017// TI - Tumor Mutational Burden and Response Rate to PD-1 Inhibition JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMc1713444 DO - 10.1056/NEJMc1713444 ID - Yarchoan2017 ER - TY - JOUR AU - Anagnostou, V. AU - Smith, K. N. AU - Forde, P. M. AU - Niknafs, N. AU - Bhattacharya, R. AU - White, J. AU - Zhang, T. AU - Adleff, V. AU - Phallen, J. AU - Wali, N. PY - 2017 DA - 2017// TI - Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-0828 DO - 10.1158/2159-8290.CD-16-0828 ID - Anagnostou2017 ER - TY - JOUR AU - Gao, J. AU - Ward, J. F. AU - Pettaway, C. A. AU - Shi, L. Z. AU - Subudhi, S. K. AU - Vence, L. M. AU - Zhao, H. AU - Chen, J. AU - Chen, H. AU - Efstathiou, E. PY - 2017 DA - 2017// TI - VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer JO - Nat Med VL - 23 UR - https://doi.org/10.1038/nm.4308 DO - 10.1038/nm.4308 ID - Gao2017 ER - TY - JOUR AU - George, S. AU - Miao, D. AU - Demetri, G. D. AU - Adeegbe, D. AU - Rodig, S. J. AU - Shukla, S. AU - Lipschitz, M. AU - Amin-Mansour, A. AU - Raut, C. P. AU - Carter, S. L. PY - 2017 DA - 2017// TI - Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma JO - Immunity VL - 46 UR - https://doi.org/10.1016/j.immuni.2017.02.001 DO - 10.1016/j.immuni.2017.02.001 ID - George2017 ER - TY - JOUR AU - Spranger, S. AU - Bao, R. AU - Gajewski, T. F. PY - 2015 DA - 2015// TI - Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity JO - Nature VL - 523 UR - https://doi.org/10.1038/nature14404 DO - 10.1038/nature14404 ID - Spranger2015 ER - TY - JOUR AU - Peng, W. AU - Chen, J. Q. AU - Liu, C. AU - Malu, S. AU - Creasy, C. AU - Tetzlaff, M. T. AU - Xu, C. AU - McKenzie, J. A. AU - Zhang, C. AU - Liang, X. PY - 2016 DA - 2016// TI - Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-15-0283 DO - 10.1158/2159-8290.CD-15-0283 ID - Peng2016 ER - TY - JOUR AU - Zaretsky, J. M. AU - Garcia-Diaz, A. AU - Shin, D. S. AU - Escuin-Ordinas, H. AU - Hugo, W. AU - Hu-Lieskovan, S. AU - Torrejon, D. Y. AU - Abril-Rodriguez, G. AU - Sandoval, S. AU - Barthly, L. PY - 2016 DA - 2016// TI - Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1604958 DO - 10.1056/NEJMoa1604958 ID - Zaretsky2016 ER - TY - JOUR AU - Sade-Feldman, M. AU - Jiao, Y. J. AU - Chen, J. H. AU - Rooney, M. S. AU - Barzily-Rokni, M. AU - Eliane, J. P. AU - Bjorgaard, S. L. AU - Hammond, M. R. AU - Vitzthum, H. AU - Blackmon, S. M. PY - 2017 DA - 2017// TI - Resistance to checkpoint blockade therapy through inactivation of antigen presentation JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/s41467-017-01062-w DO - 10.1038/s41467-017-01062-w ID - Sade-Feldman2017 ER - TY - JOUR AU - Chiocca, E. A. AU - Aguilar, L. K. AU - Bell, S. D. AU - Kaur, B. AU - Hardcastle, J. AU - Cavaliere, R. AU - McGregor, J. AU - Lo, S. AU - Ray-Chaudhuri, A. AU - Chakravarti, A. PY - 2011 DA - 2011// TI - Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.5222 DO - 10.1200/JCO.2011.35.5222 ID - Chiocca2011 ER - TY - JOUR AU - Sonawane, P. AU - Choi, Y. A. AU - Pandya, H. AU - Herpai, D. M. AU - Fokt, I. AU - Priebe, W. AU - Debinski, W. PY - 2017 DA - 2017// TI - Novel Molecular Multilevel Targeted Antitumor Agents JO - Cancer Transl Med VL - 3 UR - https://doi.org/10.4103/ctm.ctm_12_17 DO - 10.4103/ctm.ctm_12_17 ID - Sonawane2017 ER - TY - JOUR AU - Assi, H. AU - Candolfi, M. AU - Baker, G. AU - Mineharu, Y. AU - Lowenstein, P. R. AU - Castro, M. G. PY - 2012 DA - 2012// TI - Gene therapy for brain tumors: basic developments and clinical implementation JO - Neurosci Lett VL - 527 UR - https://doi.org/10.1016/j.neulet.2012.08.003 DO - 10.1016/j.neulet.2012.08.003 ID - Assi2012 ER - TY - JOUR AU - Cattaneo, R. AU - Russell, S. J. PY - 2017 DA - 2017// TI - How to develop viruses into anticancer weapons JO - PLoS Pathog VL - 13 UR - https://doi.org/10.1371/journal.ppat.1006190 DO - 10.1371/journal.ppat.1006190 ID - Cattaneo2017 ER - TY - JOUR AU - Waehler, R. AU - Russell, S. J. AU - Curiel, D. T. PY - 2007 DA - 2007// TI - Engineering targeted viral vectors for gene therapy JO - Nature Reviews Genetics VL - 8 UR - https://doi.org/10.1038/nrg2141 DO - 10.1038/nrg2141 ID - Waehler2007 ER - TY - JOUR AU - Guo, Z. S. AU - Thorne, S. H. AU - Bartlett, D. L. PY - 2008 DA - 2008// TI - Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses JO - Biochimica Et Biophysica Acta-Reviews on Cancer VL - 1785 UR - https://doi.org/10.1016/j.bbcan.2008.02.001 DO - 10.1016/j.bbcan.2008.02.001 ID - Guo2008 ER - TY - JOUR AU - Cattaneo, R. AU - Miest, T. AU - Shashkova, E. V. AU - Barry, M. A. PY - 2008 DA - 2008// TI - Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded JO - Nature Reviews Microbiology VL - 6 UR - https://doi.org/10.1038/nrmicro1927 DO - 10.1038/nrmicro1927 ID - Cattaneo2008 ER - TY - JOUR AU - Hartman, Z. C. AU - Wei, J. AU - Glass, O. K. AU - Guo, H. AU - Lei, G. AU - Yang, X. Y. AU - Osada, T. AU - Hobeika, A. AU - Delcayre, A. AU - Le Pecq, J. B. PY - 2011 DA - 2011// TI - Increasing vaccine potency through exosome antigen targeting JO - Vaccine VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.09.133 DO - 10.1016/j.vaccine.2011.09.133 ID - Hartman2011 ER - TY - JOUR AU - Nair, S. K. AU - Boczkowski, D. AU - Morse, M. AU - Cumming, R. I. AU - Lyerly, H. K. AU - Gilboa, E. PY - 1998 DA - 1998// TI - Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA JO - Nat Biotechnol VL - 16 UR - https://doi.org/10.1038/nbt0498-364 DO - 10.1038/nbt0498-364 ID - Nair1998 ER - TY - JOUR AU - Ren, J. AU - Gwin, W. R. AU - Zhou, X. AU - Wang, X. AU - Huang, H. AU - Jiang, N. AU - Zhou, L. AU - Agarwal, P. AU - Hobeika, A. AU - Crosby, E. PY - 2017 DA - 2017// TI - Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy JO - Oncoimmunology VL - 6 UR - https://doi.org/10.1080/2162402X.2016.1264563 DO - 10.1080/2162402X.2016.1264563 ID - Ren2017 ER - TY - JOUR AU - Hartman, Z. C. AU - Osada, T. AU - Glass, O. AU - Yang, X. Y. AU - Lei, G. J. AU - Lyerly, H. K. AU - Clay, T. M. PY - 2010 DA - 2010// TI - Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-0905 DO - 10.1158/0008-5472.CAN-10-0905 ID - Hartman2010 ER - TY - JOUR AU - Hammerich, L. AU - Binder, A. AU - Brody, J. D. PY - 2015 DA - 2015// TI - In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf JO - Mol Oncol VL - 9 UR - https://doi.org/10.1016/j.molonc.2015.10.016 DO - 10.1016/j.molonc.2015.10.016 ID - Hammerich2015 ER - TY - JOUR AU - Pierce, R. H. AU - Campbell, J. S. AU - Pai, S. I. AU - Brody, J. D. AU - Kohrt, H. E. PY - 2015 DA - 2015// TI - In-situ tumor vaccination: Bringing the fight to the tumor JO - Hum Vaccin Immunother VL - 11 UR - https://doi.org/10.1080/21645515.2015.1049779 DO - 10.1080/21645515.2015.1049779 ID - Pierce2015 ER - TY - JOUR AU - Richman, S. P. AU - Gutterman, J. U. AU - Hersh, E. M. PY - 1979 DA - 1979// TI - Cancer immunotherapy JO - Can Med Assoc J VL - 120 ID - Richman1979 ER - TY - JOUR AU - Rook, A. H. AU - Gelfand, J. M. AU - Wysocka, M. AU - Troxel, A. B. AU - Benoit, B. AU - Surber, C. AU - Elenitsas, R. AU - Buchanan, M. A. AU - Leahy, D. S. AU - Watanabe, R. PY - 2015 DA - 2015// TI - Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-02-630335 DO - 10.1182/blood-2015-02-630335 ID - Rook2015 ER - TY - JOUR AU - Lizotte, P. H. AU - Wen, A. M. AU - Sheen, M. R. AU - Fields, J. AU - Rojanasopondist, P. AU - Steinmetz, N. F. AU - Fiering, S. PY - 2016 DA - 2016// TI - In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer JO - Nat Nanotechnol VL - 11 UR - https://doi.org/10.1038/nnano.2015.292 DO - 10.1038/nnano.2015.292 ID - Lizotte2016 ER - TY - JOUR AU - Yarchoan, M. AU - Johnson, B. A. AU - Lutz, E. R. AU - Laheru, D. A. AU - Jaffee, E. M. PY - 2017 DA - 2017// TI - Targeting neoantigens to augment antitumour immunity JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2017.74 DO - 10.1038/nrc.2017.74 ID - Yarchoan2017 ER - TY - JOUR AU - Elsedawy, N. B. AU - Russell, S. J. PY - 2013 DA - 2013// TI - Oncolytic vaccines JO - Expert Rev Vaccines VL - 12 UR - https://doi.org/10.1586/14760584.2013.836912 DO - 10.1586/14760584.2013.836912 ID - Elsedawy2013 ER - TY - JOUR AU - Perez, O. D. AU - Logg, C. R. AU - Hiraoka, K. AU - Diago, O. AU - Burnett, R. AU - Inagaki, A. AU - Jolson, D. AU - Amundson, K. AU - Buckley, T. AU - Lohse, D. PY - 2012 DA - 2012// TI - Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression JO - Mol Ther VL - 20 UR - https://doi.org/10.1038/mt.2012.83 DO - 10.1038/mt.2012.83 ID - Perez2012 ER - TY - JOUR AU - Lawler, S. E. AU - Speranza, M. C. AU - Cho, C. F. AU - Chiocca, E. A. PY - 2017 DA - 2017// TI - Oncolytic Viruses in Cancer Treatment: A Review JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2016.2064 DO - 10.1001/jamaoncol.2016.2064 ID - Lawler2017 ER - TY - JOUR AU - Middlebrook, J. L. AU - Dorland, R. B. PY - 1984 DA - 1984// TI - Bacterial toxins: cellular mechanisms of action JO - Microbiol Rev VL - 48 ID - Middlebrook1984 ER - TY - JOUR AU - Uchugonova, A. AU - Zhang, Y. AU - Salz, R. AU - Liu, F. AU - Suetsugu, A. AU - Zhang, L. AU - Koenig, K. AU - Hoffman, R. M. AU - Zhao, M. PY - 2015 DA - 2015// TI - Imaging the Different Mechanisms of Prostate Cancer Cell-killing by Tumor-targeting Salmonella typhimurium A1-R JO - Anticancer Res VL - 35 ID - Uchugonova2015 ER - TY - JOUR AU - Chang, W. W. AU - Lee, C. H. PY - 2014 DA - 2014// TI - Salmonella as an innovative therapeutic antitumor agent JO - Int J Mol Sci VL - 15 UR - https://doi.org/10.3390/ijms150814546 DO - 10.3390/ijms150814546 ID - Chang2014 ER - TY - JOUR AU - Kasinskas, R. W. AU - Forbes, N. S. PY - 2007 DA - 2007// TI - Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis JO - Cancer research VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-2618 DO - 10.1158/0008-5472.CAN-06-2618 ID - Kasinskas2007 ER - TY - JOUR AU - Zhang, M. AU - Swofford, C. A. AU - Forbes, N. S. PY - 2014 DA - 2014// TI - Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice JO - International journal of cancer VL - 135 UR - https://doi.org/10.1002/ijc.28700 DO - 10.1002/ijc.28700 ID - Zhang2014 ER - TY - STD TI - St. Jean AT, Swofford CA, Brentzel ZJ, Forbes NS. Bacterial delivery of Staphylococcus aureus alpha-hemolysin causes tumor regression and necrosis in murine tumors. Molecular Therapy. 2014;22:1266–74. ID - ref81 ER - TY - JOUR AU - Seavey, M. M. AU - Maciag, P. C. AU - Al-Rawi, N. AU - Sewell, D. AU - Paterson, Y. PY - 2009 DA - 2009// TI - An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.0803742 DO - 10.4049/jimmunol.0803742 ID - Seavey2009 ER - TY - JOUR AU - Rankin, E. B. AU - Giaccia, A. J. PY - 2016 DA - 2016// TI - Hypoxic control of metastasis JO - Science VL - 352 UR - https://doi.org/10.1126/science.aaf4405 DO - 10.1126/science.aaf4405 ID - Rankin2016 ER - TY - JOUR AU - Jahangir, A. AU - Chandra, D. AU - Quispe-Tintaya, W. AU - Singh, M. AU - Selvanesan, B. C. AU - Gravekamp, C. PY - 2017 DA - 2017// TI - Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms JO - Oncoimmunology VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1342025 DO - 10.1080/2162402X.2017.1342025 ID - Jahangir2017 ER - TY - JOUR AU - Sorenson, B. S. AU - Banton, K. L. AU - Frykman, N. L. AU - Leonard, A. S. AU - Saltzman, D. A. PY - 2008 DA - 2008// TI - Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma JO - J Pediatr Surg VL - 43 UR - https://doi.org/10.1016/j.jpedsurg.2008.02.048 DO - 10.1016/j.jpedsurg.2008.02.048 ID - Sorenson2008 ER - TY - JOUR AU - Chen, D. S. AU - Mellman, I. PY - 2013 DA - 2013// TI - Oncology meets immunology: the cancer-immunity cycle JO - Immunity VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.07.012 DO - 10.1016/j.immuni.2013.07.012 ID - Chen2013 ER - TY - JOUR AU - Galluzzi, L. AU - Buque, A. AU - Kepp, O. AU - Zitvogel, L. AU - Kroemer, G. PY - 2017 DA - 2017// TI - Immunogenic cell death in cancer and infectious disease JO - Nat Rev Immunol VL - 17 UR - https://doi.org/10.1038/nri.2016.107 DO - 10.1038/nri.2016.107 ID - Galluzzi2017 ER - TY - JOUR AU - Kepp, O. AU - Senovilla, L. AU - Vitale, I. AU - Vacchelli, E. AU - Adjemian, S. AU - Agostinis, P. AU - Apetoh, L. AU - Aranda, F. AU - Barnaba, V. AU - Bloy, N. PY - 2014 DA - 2014// TI - Consensus guidelines for the detection of immunogenic cell death JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/21624011.2014.955691 DO - 10.4161/21624011.2014.955691 ID - Kepp2014 ER - TY - JOUR AU - Mogensen, T. H. PY - 2009 DA - 2009// TI - Pathogen recognition and inflammatory signaling in innate immune defenses JO - Clin Microbiol Rev VL - 22 UR - https://doi.org/10.1128/CMR.00046-08 DO - 10.1128/CMR.00046-08 ID - Mogensen2009 ER - TY - JOUR AU - Lizotte, P. H. AU - Baird, J. R. AU - Stevens, C. A. AU - Lauer, P. AU - Green, W. R. AU - Brockstedt, D. G. AU - Fiering, S. N. PY - 2014 DA - 2014// TI - Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis JO - Oncoimmunology VL - 3 UR - https://doi.org/10.4161/onci.28926 DO - 10.4161/onci.28926 ID - Lizotte2014 ER - TY - JOUR AU - Stern, C. AU - Kasnitz, N. AU - Kocijancic, D. AU - Trittel, S. AU - Riese, P. AU - Guzman, C. A. AU - Leschner, S. AU - Weiss, S. PY - 2015 DA - 2015// TI - Induction of CD4(+) and CD8(+) anti-tumor effector T cell responses by bacteria mediated tumor therapy JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29567 DO - 10.1002/ijc.29567 ID - Stern2015 ER - TY - JOUR AU - Richer, M. J. AU - Nolz, J. C. AU - Harty, J. T. PY - 2013 DA - 2013// TI - Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling JO - Immunity VL - 38 UR - https://doi.org/10.1016/j.immuni.2012.09.017 DO - 10.1016/j.immuni.2012.09.017 ID - Richer2013 ER - TY - JOUR AU - Din, M. O. AU - Danino, T. AU - Prindle, A. AU - Skalak, M. AU - Selimkhanov, J. AU - Allen, K. AU - Julio, E. AU - Atolia, E. AU - Tsimring, L. S. AU - Bhatia, S. N. AU - Hasty, J. PY - 2016 DA - 2016// TI - Synchronized cycles of bacterial lysis for in vivo delivery JO - Nature VL - 536 UR - https://doi.org/10.1038/nature18930 DO - 10.1038/nature18930 ID - Din2016 ER - TY - JOUR AU - Shizuya, H. AU - Birren, B. AU - Kim, U. J. AU - Mancino, V. AU - Slepak, T. AU - Tachiiri, Y. AU - Simon, M. PY - 1992 DA - 1992// TI - Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector JO - Proc Natl Acad Sci U S A VL - 89 UR - https://doi.org/10.1073/pnas.89.18.8794 DO - 10.1073/pnas.89.18.8794 ID - Shizuya1992 ER - TY - JOUR AU - Forbes, N. S. PY - 2006 DA - 2006// TI - Profile of a bacterial tumor killer JO - Nature biotechnology VL - 24 UR - https://doi.org/10.1038/nbt1206-1484 DO - 10.1038/nbt1206-1484 ID - Forbes2006 ER - TY - JOUR AU - Mengesha, A. AU - Dubois, L. AU - Lambin, P. AU - Landuyt, W. AU - Chiu, R. K. AU - Wouters, B. G. AU - Theys, J. PY - 2006 DA - 2006// TI - Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella JO - Cancer Biology & Therapy VL - 5 UR - https://doi.org/10.4161/cbt.5.9.2951 DO - 10.4161/cbt.5.9.2951 ID - Mengesha2006 ER - TY - JOUR AU - Arrach, N. AU - Zhao, M. AU - Porwollik, S. AU - Hoffman, R. M. AU - McClelland, M. PY - 2008 DA - 2008// TI - Salmonella promoters preferentially activated inside tumors JO - Cancer research VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0552 DO - 10.1158/0008-5472.CAN-08-0552 ID - Arrach2008 ER - TY - JOUR AU - Swofford, C. A. AU - Van Dessel, N. AU - Forbes, N. S. PY - 2015 DA - 2015// TI - Quorum-sensing Salmonella selectively trigger protein expression within tumors JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1414558112 DO - 10.1073/pnas.1414558112 ID - Swofford2015 ER - TY - JOUR AU - Jiang, S. N. AU - Phan, T. X. AU - Nam, T. K. AU - Nguyen, V. H. AU - Kim, H. S. AU - Bom, H. S. AU - Choy, H. E. AU - Hong, Y. AU - Min, J. J. PY - 2010 DA - 2010// TI - Inhibition of Tumor Growth and Metastasis by a Combination of Escherichia coli-mediated Cytolytic Therapy and Radiotherapy JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2009.295 DO - 10.1038/mt.2009.295 ID - Jiang2010 ER - TY - JOUR AU - Ryan, R. M. AU - Green, J. AU - Williams, P. J. AU - Tazzyman, S. AU - Hunt, S. AU - Harmey, J. H. AU - Kehoe, S. C. AU - Lewis, C. E. PY - 2009 DA - 2009// TI - Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors JO - Gene Ther VL - 16 UR - https://doi.org/10.1038/gt.2008.188 DO - 10.1038/gt.2008.188 ID - Ryan2009 ER - TY - JOUR AU - St Jean, A. T. AU - Swofford, C. A. AU - Panteli, J. T. AU - Brentzel, Z. J. AU - Forbes, N. S. PY - 2014 DA - 2014// TI - Bacterial delivery of Staphylococcus aureus alpha-hemolysin causes regression and necrosis in murine tumors JO - Mol Ther VL - 22 UR - https://doi.org/10.1038/mt.2014.36 DO - 10.1038/mt.2014.36 ID - St Jean2014 ER - TY - JOUR AU - Swofford, C. A. AU - St Jean, A. T. AU - Panteli, J. T. AU - Brentzel, Z. J. AU - Forbes, N. S. PY - 2014 DA - 2014// TI - Identification of Staphylococcus aureus alpha-hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells JO - Biotechnology and bioengineering VL - 111 UR - https://doi.org/10.1002/bit.25184 DO - 10.1002/bit.25184 ID - Swofford2014 ER - TY - JOUR AU - Nguyen, V. H. AU - Kim, H. S. AU - Ha, J. M. AU - Hong, Y. AU - Choy, H. E. AU - Min, J. J. PY - 2010 DA - 2010// TI - Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3453 DO - 10.1158/0008-5472.CAN-09-3453 ID - Nguyen2010 ER - TY - JOUR AU - Essmann, F. AU - Bantel, H. AU - Totzke, G. AU - Engels, I. H. AU - Sinha, B. AU - Schulze-Osthoff, K. AU - Janicke, R. U. PY - 2003 DA - 2003// TI - Staphylococcus aureus alpha-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation JO - Cell Death Differ VL - 10 UR - https://doi.org/10.1038/sj.cdd.4401301 DO - 10.1038/sj.cdd.4401301 ID - Essmann2003 ER - TY - JOUR AU - Gouaux, E. PY - 1998 DA - 1998// TI - alpha-hemolysin from Staphylococcus aureus: An archetype of beta-barrel, channel-forming toxins JO - Journal of Structural Biology VL - 121 UR - https://doi.org/10.1006/jsbi.1998.3959 DO - 10.1006/jsbi.1998.3959 ID - Gouaux1998 ER - TY - JOUR AU - Song, L. Z. AU - Hobaugh, M. R. AU - Shustak, C. AU - Cheley, S. AU - Bayley, H. AU - Gouaux, J. E. PY - 1996 DA - 1996// TI - Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore JO - Science VL - 274 UR - https://doi.org/10.1126/science.274.5294.1859 DO - 10.1126/science.274.5294.1859 ID - Song1996 ER - TY - JOUR AU - Menestrina, G. AU - Dalla Serra, M. AU - Comai, M. AU - Coraiola, M. AU - Viero, G. AU - Werner, S. AU - Colin, D. A. AU - Monteil, H. AU - Prevost, G. PY - 2003 DA - 2003// TI - Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus JO - FEBS Lett VL - 552 UR - https://doi.org/10.1016/S0014-5793(03)00850-0 DO - 10.1016/S0014-5793(03)00850-0 ID - Menestrina2003 ER - TY - JOUR AU - Loeffler, M. AU - Le'Negrate, G. AU - Krajewska, M. AU - Reed, J. C. PY - 2008 DA - 2008// TI - Inhibition of tumor growth using salmonella expressing Fas ligand JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn205 DO - 10.1093/jnci/djn205 ID - Loeffler2008 ER - TY - JOUR AU - Theys, J. AU - Nuyts, S. AU - Landuyt, W. AU - Van Mellaert, L. AU - Dillen, C. AU - Bohringer, M. AU - Durre, P. AU - Lambin, P. AU - Anne, J. PY - 1999 DA - 1999// TI - Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha JO - Applied and Environmental Microbiology VL - 65 ID - Theys1999 ER - TY - JOUR AU - Nuyts, S. AU - Theys, J. AU - Landuyt, W. AU - van Mellaert, L. AU - Lambin, P. AU - Anne, J. PY - 2001 DA - 2001// TI - Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters JO - Anticancer Res VL - 21 ID - Nuyts2001 ER - TY - JOUR AU - Nuyts, S. AU - Van Mellaert, L. AU - Theys, J. AU - Landuyt, W. AU - Bosmans, E. AU - Anne, J. AU - Lambin, P. PY - 2001 DA - 2001// TI - Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation JO - Gene Ther VL - 8 UR - https://doi.org/10.1038/sj.gt.3301499 DO - 10.1038/sj.gt.3301499 ID - Nuyts2001 ER - TY - JOUR AU - Walczak, H. AU - Miller, R. E. AU - Ariail, K. AU - Gliniak, B. AU - Griffith, T. S. AU - Kubin, M. AU - Chin, W. AU - Jones, J. AU - Woodward, A. AU - Le, T. PY - 1999 DA - 1999// TI - Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo JO - Nat Med VL - 5 UR - https://doi.org/10.1038/5517 DO - 10.1038/5517 ID - Walczak1999 ER - TY - JOUR AU - Quispe-Tintaya, W. AU - Chandra, D. AU - Jahangir, A. AU - Harris, M. AU - Casadevall, A. AU - Dadachova, E. AU - Gravekamp, C. PY - 2013 DA - 2013// TI - Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1211287110 DO - 10.1073/pnas.1211287110 ID - Quispe-Tintaya2013 ER - TY - JOUR AU - Chandra, D. AU - Selvanesan, B. C. AU - Yuan, Z. AU - Libutti, S. K. AU - Koba, W. AU - Beck, A. AU - Zhu, K. AU - Casadevall, A. AU - Dadachova, E. AU - Gravekamp, C. PY - 2017 DA - 2017// TI - 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.15117 DO - 10.18632/oncotarget.15117 ID - Chandra2017 ER - TY - JOUR AU - Xiang, S. AU - Fruehauf, J. AU - Li, C. J. PY - 2006 DA - 2006// TI - Short hairpin RNA-expressing bacteria elicit RNA interference in mammals JO - Nat Biotechnol VL - 24 UR - https://doi.org/10.1038/nbt1211 DO - 10.1038/nbt1211 ID - Xiang2006 ER - TY - JOUR AU - Kanai, R. AU - Rabkin, S. D. AU - Yip, S. AU - Sgubin, D. AU - Zaupa, C. M. AU - Hirose, Y. AU - Louis, D. N. AU - Wakimoto, H. AU - Martuza, R. L. PY - 2012 DA - 2012// TI - Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells JO - J Natl Cancer Inst VL - 104 UR - https://doi.org/10.1093/jnci/djr509 DO - 10.1093/jnci/djr509 ID - Kanai2012 ER - TY - JOUR AU - Waters, A. M. AU - Johnston, J. M. AU - Reddy, A. T. AU - Fiveash, J. AU - Madan-Swain, A. AU - Kachurak, K. AU - Bag, A. K. AU - Gillespie, G. Y. AU - Markert, J. M. AU - Friedman, G. K. PY - 2017 DA - 2017// TI - Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors JO - Hum Gene Ther Clin Dev VL - 28 UR - https://doi.org/10.1089/humc.2017.002 DO - 10.1089/humc.2017.002 ID - Waters2017 ER - TY - JOUR AU - Heimberger, A. B. AU - Sun, W. AU - Hussain, S. F. AU - Dey, M. AU - Crutcher, L. AU - Aldape, K. AU - Gilbert, M. AU - Hassenbusch, S. J. AU - Sawaya, R. AU - Schmittling, B. PY - 2008 DA - 2008// TI - Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study JO - Neuro Oncol VL - 10 UR - https://doi.org/10.1215/15228517-2007-046 DO - 10.1215/15228517-2007-046 ID - Heimberger2008 ER - TY - JOUR AU - Roulstone, V. AU - Khan, K. AU - Pandha, H. S. AU - Rudman, S. AU - Coffey, M. AU - Gill, G. M. AU - Melcher, A. A. AU - Vile, R. AU - Harrington, K. J. AU - de Bono, J. AU - Spicer, J. PY - 2015 DA - 2015// TI - Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1770 DO - 10.1158/1078-0432.CCR-14-1770 ID - Roulstone2015 ER - TY - JOUR AU - Durham, N. M. AU - Mulgrew, K. AU - McGlinchey, K. AU - Monks, N. R. AU - Ji, H. AU - Herbst, R. AU - Suzich, J. AU - Hammond, S. A. AU - Kelly, E. J. PY - 2017 DA - 2017// TI - Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy JO - Mol Ther VL - 25 UR - https://doi.org/10.1016/j.ymthe.2017.05.006 DO - 10.1016/j.ymthe.2017.05.006 ID - Durham2017 ER - TY - JOUR AU - Moesta, A. K. AU - Cooke, K. AU - Piasecki, J. AU - Mitchell, P. AU - Rottman, J. B. AU - Fitzgerald, K. AU - Zhan, J. AU - Yang, B. AU - Le, T. AU - Belmontes, B. PY - 2017 DA - 2017// TI - Local Delivery of OncoVEX(mGM-CSF) Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-17-0681 DO - 10.1158/1078-0432.CCR-17-0681 ID - Moesta2017 ER - TY - JOUR AU - Rajani, K. AU - Parrish, C. AU - Kottke, T. AU - Thompson, J. AU - Zaidi, S. AU - Ilett, L. AU - Shim, K. G. AU - Diaz, R. M. AU - Pandha, H. AU - Harrington, K. PY - 2016 DA - 2016// TI - Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2015.156 DO - 10.1038/mt.2015.156 ID - Rajani2016 ER - TY - JOUR AU - Woller, N. AU - Gurlevik, E. AU - Fleischmann-Mundt, B. AU - Schumacher, A. AU - Knocke, S. AU - Kloos, A. M. AU - Saborowski, M. AU - Geffers, R. AU - Manns, M. P. AU - Wirth, T. C. PY - 2015 DA - 2015// TI - Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses JO - Mol Ther VL - 23 UR - https://doi.org/10.1038/mt.2015.115 DO - 10.1038/mt.2015.115 ID - Woller2015 ER - TY - JOUR AU - Zamarin, D. AU - Wolchok, J. D. PY - 2014 DA - 2014// TI - Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer JO - Mol Ther Oncolytics VL - 1 UR - https://doi.org/10.1038/mto.2014.4 DO - 10.1038/mto.2014.4 ID - Zamarin2014 ER - TY - STD TI - Chesney J, Puzanov I, Collichio F, Singh P, Milhem MM, Glaspy J, Hamid O, Ross M, Friedlander P, Garbe C, et al. Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma. J Clin Oncol. 2018;36:1658. ID - ref125 ER - TY - JOUR AU - Ribas, A. AU - Dummer, R. AU - Puzanov, I. AU - VanderWalde, A. AU - Andtbacka, R. H. I. AU - Michielin, O. AU - Olszanski, A. J. AU - Malvehy, J. AU - Cebon, J. AU - Fernandez, E. PY - 2017 DA - 2017// TI - Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.08.027 DO - 10.1016/j.cell.2017.08.027 ID - Ribas2017 ER - TY - JOUR AU - Nishio, N. AU - Diaconu, I. AU - Liu, H. AU - Cerullo, V. AU - Caruana, I. AU - Hoyos, V. AU - Bouchier-Hayes, L. AU - Savoldo, B. AU - Dotti, G. PY - 2014 DA - 2014// TI - Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0697 DO - 10.1158/0008-5472.CAN-14-0697 ID - Nishio2014 ER - TY - JOUR AU - Rosewell Shaw, A. AU - Porter, C. E. AU - Watanabe, N. AU - Tanoue, K. AU - Sikora, A. AU - Gottschalk, S. AU - Brenner, M. K. AU - Suzuki, M. PY - 2017 DA - 2017// TI - Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer JO - Mol Ther VL - 25 UR - https://doi.org/10.1016/j.ymthe.2017.09.010 DO - 10.1016/j.ymthe.2017.09.010 ID - Rosewell Shaw2017 ER - TY - JOUR AU - Tanoue, K. AU - Rosewell Shaw, A. AU - Watanabe, N. AU - Porter, C. AU - Rana, B. AU - Gottschalk, S. AU - Brenner, M. AU - Suzuki, M. PY - 2017 DA - 2017// TI - Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1577 DO - 10.1158/0008-5472.CAN-16-1577 ID - Tanoue2017 ER - TY - JOUR AU - Lambin, P. AU - Theys, J. AU - Landuyt, W. AU - Rijken, P. AU - van der Kogel, A. AU - van der Schueren, E. AU - Hodgkiss, R. AU - Fowler, J. AU - Nuyts, S. AU - de Bruijn, E. PY - 1998 DA - 1998// TI - Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours JO - Anaerobe VL - 4 UR - https://doi.org/10.1006/anae.1998.0161 DO - 10.1006/anae.1998.0161 ID - Lambin1998 ER - TY - JOUR AU - Westphal, K. AU - Leschner, S. AU - Jablonska, J. AU - Loessner, H. AU - Weiss, S. PY - 2008 DA - 2008// TI - Containment of tumor-colonizing bacteria by host neutrophils JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2984 DO - 10.1158/0008-5472.CAN-07-2984 ID - Westphal2008 ER - TY - JOUR AU - Dang, L. H. AU - Bettegowda, C. AU - Agrawal, N. AU - Cheong, I. AU - Huso, D. AU - Frost, P. AU - Loganzo, F. AU - Greenberger, L. AU - Barkoczy, J. AU - Pettit, G. R. PY - 2004 DA - 2004// TI - Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents JO - Cancer Biol Ther VL - 3 UR - https://doi.org/10.4161/cbt.3.3.704 DO - 10.4161/cbt.3.3.704 ID - Dang2004 ER - TY - JOUR AU - Bettegowda, C. AU - Dang, L. H. AU - Abrams, R. AU - Huso, D. L. AU - Dillehay, L. AU - Cheong, I. AU - Agrawal, N. AU - Borzillary, S. AU - McCaffery, J. M. AU - Watson, E. L. PY - 2003 DA - 2003// TI - Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.2036598100 DO - 10.1073/pnas.2036598100 ID - Bettegowda2003 ER - TY - JOUR AU - Hedley, D. AU - Ogilvie, L. AU - Springer, C. PY - 2007 DA - 2007// TI - Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2247 DO - 10.1038/nrc2247 ID - Hedley2007 ER - TY - JOUR AU - Pawelek, J. M. AU - Low, K. B. AU - Bermudes, D. PY - 1997 DA - 1997// TI - Tumor-targeted Salmonella as a novel anticancer vector JO - Cancer Res VL - 57 ID - Pawelek1997 ER - TY - JOUR AU - Stritzker, J. AU - Pilgrim, S. AU - Szalay, A. A. AU - Goebel, W. PY - 2008 DA - 2008// TI - Prodrug converting enzyme gene delivery by L. monocytogenes JO - BMC Cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-94 DO - 10.1186/1471-2407-8-94 ID - Stritzker2008 ER - TY - STD TI - Gulley JL, Madan RA, Pachynski R, Mulders P, Sheikh NA, Trager J, Drake CG. Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment. J Natl Cancer Inst. 2017;109 ID - ref137 ER - TY - JOUR AU - Hodge, J. W. AU - Sabzevari, H. AU - Yafal, A. G. AU - Gritz, L. AU - Lorenz, M. G. AU - Schlom, J. PY - 1999 DA - 1999// TI - A triad of costimulatory molecules synergize to amplify T-cell activation JO - Cancer Res VL - 59 ID - Hodge1999 ER - TY - JOUR AU - Madan, R. A. AU - Arlen, P. M. AU - Mohebtash, M. AU - Hodge, J. W. AU - Gulley, J. L. PY - 2009 DA - 2009// TI - Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer JO - Expert Opin Investig Drugs VL - 18 UR - https://doi.org/10.1517/13543780902997928 DO - 10.1517/13543780902997928 ID - Madan2009 ER - TY - JOUR AU - Bazett, M. AU - Costa, A. M. AU - Bosiljcic, M. AU - Anderson, R. M. AU - Alexander, M. P. AU - Wong, S. W. Y. AU - Dhanji, S. AU - Chen, J. M. AU - Pankovich, J. AU - Lam, S. PY - 2018 DA - 2018// TI - Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2017.1398875 DO - 10.1080/2162402X.2017.1398875 ID - Bazett2018 ER - TY - JOUR AU - You, Y. N. AU - Lakhani, V. T. AU - Wells, S. A. PY - 2007 DA - 2007// TI - The role of prophylactic surgery in cancer prevention JO - World J Surg VL - 31 UR - https://doi.org/10.1007/s00268-006-0616-1 DO - 10.1007/s00268-006-0616-1 ID - You2007 ER - TY - JOUR AU - Bhatt, A. P. AU - Redinbo, M. R. AU - Bultman, S. J. PY - 2017 DA - 2017// TI - The role of the microbiome in cancer development and therapy JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21398 DO - 10.3322/caac.21398 ID - Bhatt2017 ER - TY - JOUR AU - Frazer, I. H. AU - Quinn, M. AU - Nicklin, J. L. AU - Tan, J. AU - Perrin, L. C. AU - Ng, P. AU - O'Connor, V. M. AU - White, O. AU - Wendt, N. AU - Martin, J. PY - 2004 DA - 2004// TI - Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia JO - Vaccine VL - 23 UR - https://doi.org/10.1016/j.vaccine.2004.05.013 DO - 10.1016/j.vaccine.2004.05.013 ID - Frazer2004 ER - TY - JOUR AU - Schiller, J. T. AU - Lowy, D. R. PY - 2006 DA - 2006// TI - Prospects for cervical cancer prevention by human papillomavirus vaccination JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-0630 DO - 10.1158/0008-5472.CAN-06-0630 ID - Schiller2006 ER - TY - JOUR AU - Hilleman, M. R. AU - Buynak, E. B. AU - Roehm, R. R. AU - Tytell, A. A. AU - Bertland, A. U. AU - Lampson, G. P. PY - 1975 DA - 1975// TI - Purified and inactivated human hepatitis B vaccine: progress report JO - Am J Med Sci VL - 270 UR - https://doi.org/10.1097/00000441-197509000-00025 DO - 10.1097/00000441-197509000-00025 ID - Hilleman1975 ER - TY - JOUR AU - Gatti-Mays, M. E. AU - Redman, J. M. AU - Collins, J. M. AU - Bilusic, M. PY - 2017 DA - 2017// TI - Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations JO - Hum Vaccin Immunother VL - 13 UR - https://doi.org/10.1080/21645515.2017.1364322 DO - 10.1080/21645515.2017.1364322 ID - Gatti-Mays2017 ER - TY - JOUR AU - Kaur, B. AU - Chiocca, E. A. AU - Cripe, T. P. PY - 2012 DA - 2012// TI - Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress JO - Curr Pharm Biotechnol VL - 13 UR - https://doi.org/10.2174/138920112800958814 DO - 10.2174/138920112800958814 ID - Kaur2012 ER - TY - JOUR AU - Bell, J. AU - McFadden, G. PY - 2014 DA - 2014// TI - Viruses for tumor therapy JO - Cell Host Microbe VL - 15 UR - https://doi.org/10.1016/j.chom.2014.01.002 DO - 10.1016/j.chom.2014.01.002 ID - Bell2014 ER - TY - JOUR AU - Cunningham, C. AU - Nemunaitis, J. PY - 2001 DA - 2001// TI - A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001 JO - Hum Gene Ther VL - 12 ID - Cunningham2001 ER - TY - JOUR AU - Toso, J. F. AU - Gill, V. J. AU - Hwu, P. AU - Marincola, F. M. AU - Restifo, N. P. AU - Schwartzentruber, D. J. AU - Sherry, R. M. AU - Topalian, S. L. AU - Yang, J. C. AU - Stock, F. PY - 2002 DA - 2002// TI - Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.20.1.142 DO - 10.1200/JCO.2002.20.1.142 ID - Toso2002 ER - TY - JOUR AU - Heimann, D. M. AU - Rosenberg, S. A. PY - 2003 DA - 2003// TI - Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma JO - J Immunother VL - 26 UR - https://doi.org/10.1097/00002371-200303000-00011 DO - 10.1097/00002371-200303000-00011 ID - Heimann2003 ER - TY - JOUR AU - Nemunaitis, J. AU - Cunningham, C. AU - Senzer, N. AU - Kuhn, J. AU - Cramm, J. AU - Litz, C. AU - Cavagnolo, R. AU - Cahill, A. AU - Clairmont, C. AU - Sznol, M. PY - 2003 DA - 2003// TI - Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients JO - Cancer Gene Ther VL - 10 UR - https://doi.org/10.1038/sj.cgt.7700634 DO - 10.1038/sj.cgt.7700634 ID - Nemunaitis2003 ER - TY - JOUR AU - Fritz, S. E. AU - Henson, M. S. AU - Greengard, E. AU - Winter, A. L. AU - Stuebner, K. M. AU - Yoon, U. AU - Wilk, V. L. AU - Borgatti, A. AU - Augustin, L. B. AU - Modiano, J. F. AU - Saltzman, D. A. PY - 2016 DA - 2016// TI - A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma JO - Vet Med Sci VL - 2 UR - https://doi.org/10.1002/vms3.32 DO - 10.1002/vms3.32 ID - Fritz2016 ER - TY - JOUR AU - Krick, E. L. AU - Sorenmo, K. U. AU - Rankin, S. C. AU - Cheong, I. AU - Kobrin, B. AU - Thornton, K. AU - Kinzler, K. W. AU - Vogelstein, B. AU - Zhou, S. AU - Diaz, L. A. PY - 2012 DA - 2012// TI - Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors JO - Am J Vet Res VL - 73 UR - https://doi.org/10.2460/ajvr.73.1.112 DO - 10.2460/ajvr.73.1.112 ID - Krick2012 ER - TY - JOUR AU - Kashiwagi, N. AU - Nakanishi, K. AU - Kozuka, T. AU - Sato, Y. AU - Tanaka, K. AU - Tsukaguchi, I. AU - Uemura, H. AU - Fujii, T. AU - Yoshino, K. AU - Tomiyama, N. PY - 2010 DA - 2010// TI - Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer JO - Br J Radiol VL - 83 UR - https://doi.org/10.1259/bjr/16954991 DO - 10.1259/bjr/16954991 ID - Kashiwagi2010 ER - TY - JOUR AU - Egeland, T. A. AU - Gaustad, J. V. AU - Galappathi, K. AU - Rofstad, E. K. PY - 2011 DA - 2011// TI - Magnetic resonance imaging of tumor necrosis JO - Acta Oncol VL - 50 UR - https://doi.org/10.3109/0284186X.2010.526633 DO - 10.3109/0284186X.2010.526633 ID - Egeland2011 ER - TY - JOUR AU - Fleming, I. N. AU - Manavaki, R. AU - Blower, P. J. AU - West, C. AU - Williams, K. J. AU - Harris, A. L. AU - Domarkas, J. AU - Lord, S. AU - Baldry, C. AU - Gilbert, F. J. PY - 2015 DA - 2015// TI - Imaging tumour hypoxia with positron emission tomography JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2014.610 DO - 10.1038/bjc.2014.610 ID - Fleming2015 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. AU - Shintaku, I. P. AU - Taylor, E. J. AU - Robert, L. AU - Chmielowski, B. AU - Spasic, M. AU - Henry, G. AU - Ciobanu, V. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Margolis, S. R. AU - Wilson, S. C. AU - Vance, R. E. PY - 2017 DA - 2017// TI - Evolutionary Origins of cGAS-STING Signaling JO - Trends Immunol VL - 38 UR - https://doi.org/10.1016/j.it.2017.03.004 DO - 10.1016/j.it.2017.03.004 ID - Margolis2017 ER - TY - JOUR AU - Hildner, K. AU - Edelson, B. T. AU - Purtha, W. E. AU - Diamond, M. AU - Matsushita, H. AU - Kohyama, M. AU - Calderon, B. AU - Schraml, B. U. AU - Unanue, E. R. AU - Diamond, M. S. PY - 2008 DA - 2008// TI - Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity JO - Science VL - 322 UR - https://doi.org/10.1126/science.1164206 DO - 10.1126/science.1164206 ID - Hildner2008 ER - TY - JOUR AU - Ginhoux, F. AU - Liu, K. AU - Helft, J. AU - Bogunovic, M. AU - Greter, M. AU - Hashimoto, D. AU - Price, J. AU - Yin, N. AU - Bromberg, J. AU - Lira, S. A. PY - 2009 DA - 2009// TI - The origin and development of nonlymphoid tissue CD103+ DCs JO - J Exp Med VL - 206 UR - https://doi.org/10.1084/jem.20091756 DO - 10.1084/jem.20091756 ID - Ginhoux2009 ER - TY - JOUR AU - Zhang, Y. AU - Chen, G. AU - Liu, Z. AU - Tian, S. AU - Zhang, J. AU - Carey, C. D. AU - Murphy, K. M. AU - Storkus, W. J. AU - Falo, L. D. AU - You, Z. PY - 2015 DA - 2015// TI - Genetic Vaccines To Potentiate the Effective CD103+ Dendritic Cell-Mediated Cross-Priming of Antitumor Immunity JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1500089 DO - 10.4049/jimmunol.1500089 ID - Zhang2015 ER - TY - JOUR AU - Callahan, M. K. AU - Wolchok, J. D. PY - 2013 DA - 2013// TI - At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy JO - J Leukoc Biol VL - 94 UR - https://doi.org/10.1189/jlb.1212631 DO - 10.1189/jlb.1212631 ID - Callahan2013 ER - TY - JOUR AU - Zhou, S. AU - Bettegowda, C. AU - Agrawal, N. PY - 2004 DA - 2004// TI - Combination bacteriolytic cancer therapy: Attacking cancer from inside out JO - Discov Med VL - 4 ID - Zhou2004 ER - TY - JOUR AU - Minton, N. P. PY - 2003 DA - 2003// TI - Clostridia in cancer therapy JO - Nature Reviews Microbiology VL - 1 UR - https://doi.org/10.1038/nrmicro777 DO - 10.1038/nrmicro777 ID - Minton2003 ER - TY - JOUR AU - Leschner, S. AU - Westphal, K. AU - Dietrich, N. AU - Viegas, N. AU - Jablonska, J. AU - Lyszkiewicz, M. AU - Lienenklaus, S. AU - Falk, W. AU - Gekara, N. AU - Loessner, H. AU - Weiss, S. PY - 2009 DA - 2009// TI - Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha JO - PloS one VL - 4 UR - https://doi.org/10.1371/journal.pone.0006692 DO - 10.1371/journal.pone.0006692 ID - Leschner2009 ER - TY - JOUR AU - Forbes, N. S. AU - Munn, L. L. AU - Fukumura, D. AU - Jain, R. K. PY - 2003 DA - 2003// TI - Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors JO - Cancer Res VL - 63 ID - Forbes2003 ER - TY - JOUR AU - Kasinskas, R. W. AU - Forbes, N. S. PY - 2006 DA - 2006// TI - Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro JO - Biotechnology and Bioengineering VL - 94 UR - https://doi.org/10.1002/bit.20883 DO - 10.1002/bit.20883 ID - Kasinskas2006 ER - TY - JOUR AU - Chandra, D. AU - Jahangir, A. AU - Quispe-Tintaya, W. AU - Einstein, M. H. AU - Gravekamp, C. PY - 2013 DA - 2013// TI - Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice JO - British journal of cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.206 DO - 10.1038/bjc.2013.206 ID - Chandra2013 ER - TY - JOUR AU - Chandra, D. AU - Gravekamp, C. PY - 2013 DA - 2013// TI - Myeloid-derived suppressor cells: Cellular missiles to target tumors JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.26967 DO - 10.4161/onci.26967 ID - Chandra2013 ER - TY - JOUR AU - Ostrand-Rosenberg, S. AU - Sinha, P. PY - 2009 DA - 2009// TI - Myeloid-derived suppressor cells: linking inflammation and cancer JO - Journal of immunology VL - 182 UR - https://doi.org/10.4049/jimmunol.0802740 DO - 10.4049/jimmunol.0802740 ID - Ostrand-Rosenberg2009 ER - TY - JOUR AU - Hiratsuka, S. AU - Watanabe, A. AU - Aburatani, H. AU - Maru, Y. PY - 2006 DA - 2006// TI - Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis JO - Nature cell biology VL - 8 UR - https://doi.org/10.1038/ncb1507 DO - 10.1038/ncb1507 ID - Hiratsuka2006 ER - TY - JOUR AU - Tilney, L. G. AU - Portnoy, D. A. PY - 1989 DA - 1989// TI - Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes JO - J Cell Biol VL - 109 UR - https://doi.org/10.1083/jcb.109.4.1597 DO - 10.1083/jcb.109.4.1597 ID - Tilney1989 ER - TY - JOUR AU - Sznol, M. AU - Lin, S. L. AU - Bermudes, D. AU - Zheng, L. M. AU - King, I. PY - 2000 DA - 2000// TI - Use of preferentially replicating bacteria for the treatment of cancer JO - J Clin Invest VL - 105 UR - https://doi.org/10.1172/JCI9818 DO - 10.1172/JCI9818 ID - Sznol2000 ER - TY - JOUR AU - Thorne, S. H. PY - 2007 DA - 2007// TI - Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors JO - Expert Opin Biol Ther VL - 7 UR - https://doi.org/10.1517/14712598.7.1.41 DO - 10.1517/14712598.7.1.41 ID - Thorne2007 ER - TY - JOUR AU - Kueberuwa, G. AU - Cawood, R. AU - Seymour, L. W. PY - 2010 DA - 2010// TI - Blood compatibility of enveloped viruses JO - Current opinion in molecular therapeutics VL - 12 ID - Kueberuwa2010 ER - TY - JOUR AU - Fountzilas, C. AU - Patel, S. AU - Mahalingam, D. PY - 2017 DA - 2017// TI - Review: Oncolytic virotherapy, updates and future directions JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.18309 DO - 10.18632/oncotarget.18309 ID - Fountzilas2017 ER - TY - JOUR AU - Morrison, J. AU - Briggs, S. S. AU - Green, N. AU - Fisher, K. AU - Subr, V. AU - Ulbrich, K. AU - Kehoe, S. AU - Seymour, L. W. PY - 2008 DA - 2008// TI - Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor JO - Mol Ther VL - 16 UR - https://doi.org/10.1038/sj.mt.6300363 DO - 10.1038/sj.mt.6300363 ID - Morrison2008 ER - TY - JOUR AU - Kwon, O. J. AU - Kang, E. AU - Choi, J. W. AU - Kim, S. W. AU - Yun, C. O. PY - 2013 DA - 2013// TI - Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy JO - J Control Release VL - 169 UR - https://doi.org/10.1016/j.jconrel.2013.03.030 DO - 10.1016/j.jconrel.2013.03.030 ID - Kwon2013 ER - TY - JOUR AU - Tian, J. AU - Xu, Z. AU - Smith, J. S. AU - Hofherr, S. E. AU - Barry, M. A. AU - Byrnes, A. P. PY - 2009 DA - 2009// TI - Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo JO - J Virol VL - 83 UR - https://doi.org/10.1128/JVI.00082-09 DO - 10.1128/JVI.00082-09 ID - Tian2009 ER - TY - JOUR AU - Carlisle, R. AU - Choi, J. AU - Bazan-Peregrino, M. AU - Laga, R. AU - Subr, V. AU - Kostka, L. AU - Ulbrich, K. AU - Coussios, C. C. AU - Seymour, L. W. PY - 2013 DA - 2013// TI - Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt305 DO - 10.1093/jnci/djt305 ID - Carlisle2013 ER - TY - JOUR AU - Zhang, X. AU - Huang, Y. AU - Ghazwani, M. AU - Zhang, P. AU - Li, J. AU - Thorne, S. H. AU - Li, S. PY - 2015 DA - 2015// TI - Tunable pH-responsive polymeric micelle for cancer treatment JO - ACS Macro Letters VL - 4 UR - https://doi.org/10.1021/acsmacrolett.5b00165 DO - 10.1021/acsmacrolett.5b00165 ID - Zhang2015 ER - TY - JOUR AU - Fisher, K. D. AU - Stallwood, Y. AU - Green, N. K. AU - Ulbrich, K. AU - Mautner, V. AU - Seymour, L. W. PY - 2001 DA - 2001// TI - Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies JO - Gene Ther VL - 8 UR - https://doi.org/10.1038/sj.gt.3301389 DO - 10.1038/sj.gt.3301389 ID - Fisher2001 ER - TY - JOUR AU - Evgin, L. AU - Acuna, S. A. AU - Tanese de Souza, C. AU - Marguerie, M. AU - Lemay, C. G. AU - Ilkow, C. S. AU - Findlay, C. S. AU - Falls, T. AU - Parato, K. A. AU - Hanwell, D. PY - 2015 DA - 2015// TI - Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques JO - Mol Ther VL - 23 UR - https://doi.org/10.1038/mt.2015.49 DO - 10.1038/mt.2015.49 ID - Evgin2015 ER - TY - JOUR AU - Ilett, E. AU - Kottke, T. AU - Donnelly, O. AU - Thompson, J. AU - Willmon, C. AU - Diaz, R. AU - Zaidi, S. AU - Coffey, M. AU - Selby, P. AU - Harrington, K. PY - 2014 DA - 2014// TI - Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus JO - Mol Ther VL - 22 UR - https://doi.org/10.1038/mt.2014.118 DO - 10.1038/mt.2014.118 ID - Ilett2014 ER - TY - JOUR AU - Rojas, J. J. AU - Sampath, P. AU - Bonilla, B. AU - Ashley, A. AU - Hou, W. AU - Byrd, D. AU - Thorne, S. H. PY - 2016 DA - 2016// TI - Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies JO - Cell Rep VL - 15 UR - https://doi.org/10.1016/j.celrep.2016.03.017 DO - 10.1016/j.celrep.2016.03.017 ID - Rojas2016 ER - TY - JOUR AU - Kuhn, I. AU - Harden, P. AU - Bauzon, M. AU - Chartier, C. AU - Nye, J. AU - Thorne, S. AU - Reid, T. AU - Ni, S. AU - Lieber, A. AU - Fisher, K. PY - 2008 DA - 2008// TI - Directed evolution generates a novel oncolytic virus for the treatment of colon cancer JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0002409 DO - 10.1371/journal.pone.0002409 ID - Kuhn2008 ER - TY - JOUR AU - Thorne, S. H. AU - Contag, C. H. PY - 2008 DA - 2008// TI - Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery JO - Gene Ther VL - 15 UR - https://doi.org/10.1038/gt.2008.42 DO - 10.1038/gt.2008.42 ID - Thorne2008 ER - TY - JOUR AU - Adair, R. A. AU - Roulstone, V. AU - Scott, K. J. AU - Morgan, R. AU - Nuovo, G. J. AU - Fuller, M. AU - Beirne, D. AU - West, E. J. AU - Jennings, V. A. AU - Rose, A. PY - 2012 DA - 2012// TI - Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients JO - Sci Transl Med VL - 4 ID - Adair2012 ER - TY - JOUR AU - Carey, R. W. AU - Holland, J. F. AU - Whang, H. Y. AU - Neter, E. AU - Bryant, B. PY - 1967 DA - 1967// TI - Clostridial oncolysis in man JO - Europ J Cancer VL - 3 UR - https://doi.org/10.1016/0014-2964(67)90060-6 DO - 10.1016/0014-2964(67)90060-6 ID - Carey1967 ER - TY - JOUR AU - Bourquin, C. AU - von der Borch, P. AU - Zoglmeier, C. AU - Anz, D. AU - Sandholzer, N. AU - Suhartha, N. AU - Wurzenberger, C. AU - Denzel, A. AU - Kammerer, R. AU - Zimmermann, W. AU - Endres, S. PY - 2010 DA - 2010// TI - Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model JO - J Immunol VL - 185 UR - https://doi.org/10.4049/jimmunol.0903231 DO - 10.4049/jimmunol.0903231 ID - Bourquin2010 ER - TY - JOUR AU - Kersten, K. AU - de Visser, K. E. AU - van Miltenburg, M. H. AU - Jonkers, J. PY - 2017 DA - 2017// TI - Genetically engineered mouse models in oncology research and cancer medicine JO - EMBO Mol Med VL - 9 UR - https://doi.org/10.15252/emmm.201606857 DO - 10.15252/emmm.201606857 ID - Kersten2017 ER - TY - JOUR AU - Walrath, J. C. AU - Hawes, J. J. AU - Van Dyke, T. AU - Reilly, K. M. PY - 2010 DA - 2010// TI - Genetically engineered mouse models in cancer research JO - Adv Cancer Res VL - 106 UR - https://doi.org/10.1016/S0065-230X(10)06004-5 DO - 10.1016/S0065-230X(10)06004-5 ID - Walrath2010 ER - TY - JOUR AU - Gengenbacher, N. AU - Singhal, M. AU - Augustin, H. G. PY - 2017 DA - 2017// TI - Preclinical mouse solid tumour models: status quo, challenges and perspectives JO - Nat Rev Cancer VL - 17 UR - https://doi.org/10.1038/nrc.2017.92 DO - 10.1038/nrc.2017.92 ID - Gengenbacher2017 ER - TY - JOUR AU - Tschida, B. R. AU - Largaespada, D. A. AU - Keng, V. W. PY - 2014 DA - 2014// TI - Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies JO - Semin Cell Dev Biol VL - 27 UR - https://doi.org/10.1016/j.semcdb.2014.01.006 DO - 10.1016/j.semcdb.2014.01.006 ID - Tschida2014 ER - TY - JOUR AU - Tsoneva, D. AU - Minev, B. AU - Frentzen, A. AU - Zhang, Q. AU - Wege, A. K. AU - Szalay, A. A. PY - 2017 DA - 2017// TI - Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis JO - Mol Ther Oncolytics VL - 5 UR - https://doi.org/10.1016/j.omto.2017.03.001 DO - 10.1016/j.omto.2017.03.001 ID - Tsoneva2017 ER - TY - JOUR AU - LeBlanc, A. K. AU - Naik, S. AU - Galyon, G. D. AU - Jenks, N. AU - Steele, M. AU - Peng, K. W. AU - Federspiel, M. J. AU - Donnell, R. AU - Russell, S. J. PY - 2013 DA - 2013// TI - Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs JO - Hum Gene Ther Clin Dev VL - 24 UR - https://doi.org/10.1089/humc.2013.165 DO - 10.1089/humc.2013.165 ID - LeBlanc2013 ER - TY - STD TI - Hwang CC, Igase M, Sakurai M, Haraguchi T, Tani K, Itamoto K, Shimokawa T, Nakaichi M, Nemoto Y, Noguchi S, et al. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours. Vet Comp Oncol. 2018;16:229–38. ID - ref198 ER - TY - JOUR AU - Atherton, M. J. AU - Morris, J. S. AU - McDermott, M. R. AU - Lichty, B. D. PY - 2016 DA - 2016// TI - Cancer immunology and canine malignant melanoma: A comparative review JO - Vet Immunol Immunopathol VL - 169 UR - https://doi.org/10.1016/j.vetimm.2015.11.003 DO - 10.1016/j.vetimm.2015.11.003 ID - Atherton2016 ER - TY - JOUR AU - Panjwani, M. K. AU - Smith, J. B. AU - Schutsky, K. AU - Gnanandarajah, J. AU - O'Connor, C. M. AU - Powell, D. J. AU - Mason, N. J. PY - 2016 DA - 2016// TI - Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.146 DO - 10.1038/mt.2016.146 ID - Panjwani2016 ER - TY - JOUR AU - Pluhar, G. E. AU - Grogan, P. T. AU - Seiler, C. AU - Goulart, M. AU - Santacruz, K. S. AU - Carlson, C. AU - Chen, W. AU - Olin, M. R. AU - Lowenstein, P. R. AU - Castro, M. G. PY - 2010 DA - 2010// TI - Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy JO - Vaccine VL - 28 UR - https://doi.org/10.1016/j.vaccine.2010.02.082 DO - 10.1016/j.vaccine.2010.02.082 ID - Pluhar2010 ER - TY - JOUR AU - Regan, D. AU - Guth, A. AU - Coy, J. AU - Dow, S. PY - 2016 DA - 2016// TI - Cancer immunotherapy in veterinary medicine: Current options and new developments JO - Vet J VL - 207 UR - https://doi.org/10.1016/j.tvjl.2015.10.008 DO - 10.1016/j.tvjl.2015.10.008 ID - Regan2016 ER - TY - JOUR AU - Anderson, K. L. AU - Modiano, J. F. PY - 2015 DA - 2015// TI - Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure JO - Vet Sci VL - 2 UR - https://doi.org/10.3390/vetsci2040363 DO - 10.3390/vetsci2040363 ID - Anderson2015 ER - TY - JOUR AU - Park, J. S. AU - Withers, S. S. AU - Modiano, J. F. AU - Kent, M. S. AU - Chen, M. AU - Luna, J. I. AU - Culp, W. T. N. AU - Sparger, E. E. AU - Rebhun, R. B. AU - Monjazeb, A. M. PY - 2016 DA - 2016// TI - Canine cancer immunotherapy studies: linking mouse and human JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0200-7 DO - 10.1186/s40425-016-0200-7 ID - Park2016 ER - TY - JOUR AU - Sivan, A. AU - Corrales, L. AU - Hubert, N. AU - Williams, J. B. AU - Aquino-Michaels, K. AU - Earley, Z. M. AU - Benyamin, F. W. AU - Lei, Y. M. AU - Jabri, B. AU - Alegre, M. L. PY - 2015 DA - 2015// TI - Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy JO - Science VL - 350 UR - https://doi.org/10.1126/science.aac4255 DO - 10.1126/science.aac4255 ID - Sivan2015 ER - TY - JOUR AU - Song, S. J. AU - Lauber, C. AU - Costello, E. K. AU - Lozupone, C. A. AU - Humphrey, G. AU - Berg-Lyons, D. AU - Caporaso, J. G. AU - Knights, D. AU - Clemente, J. C. AU - Nakielny, S. PY - 2013 DA - 2013// TI - Cohabiting family members share microbiota with one another and with their dogs JO - Elife VL - 2 UR - https://doi.org/10.7554/eLife.00458 DO - 10.7554/eLife.00458 ID - Song2013 ER - TY - JOUR AU - Vetizou, M. AU - Pitt, J. M. AU - Daillere, R. AU - Lepage, P. AU - Waldschmitt, N. AU - Flament, C. AU - Rusakiewicz, S. AU - Routy, B. AU - Roberti, M. P. AU - Duong, C. P. PY - 2015 DA - 2015// TI - Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota JO - Science VL - 350 UR - https://doi.org/10.1126/science.aad1329 DO - 10.1126/science.aad1329 ID - Vetizou2015 ER - TY - JOUR AU - Dunn, G. P. AU - Old, L. J. AU - Schreiber, R. D. PY - 2004 DA - 2004// TI - The immunobiology of cancer immunosurveillance and immunoediting JO - Immunity VL - 21 UR - https://doi.org/10.1016/j.immuni.2004.07.017 DO - 10.1016/j.immuni.2004.07.017 ID - Dunn2004 ER - TY - STD TI - US FDA: Recommendations for Microbial Vectors used for Gene Therapy - Guidance for Industry (2016) [https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/ucm466625.pdf]. Accessed 15 July 2018. UR - https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/ucm466625.pdf ID - ref209 ER - TY - STD TI - Cellular, Tissue and Gene Therapies & Oncologic Drug Advisory Committee Meeting: Talimogene Laherparepvec [https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/ucm404087.pdf]. Accessed 15 July 2018. UR - https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/ucm404087.pdf ID - ref210 ER - TY - JOUR AU - Hu, J. C. AU - Coffin, R. S. AU - Davis, C. J. AU - Graham, N. J. AU - Groves, N. AU - Guest, P. J. AU - Harrington, K. J. AU - James, N. D. AU - Love, C. A. AU - McNeish, I. PY - 2006 DA - 2006// TI - A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0759 DO - 10.1158/1078-0432.CCR-06-0759 ID - Hu2006 ER - TY - JOUR AU - Harrington, K. J. AU - Hingorani, M. AU - Tanay, M. A. AU - Hickey, J. AU - Bhide, S. A. AU - Clarke, P. M. AU - Renouf, L. C. AU - Thway, K. AU - Sibtain, A. AU - McNeish, I. A. PY - 2010 DA - 2010// TI - Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0196 DO - 10.1158/1078-0432.CCR-10-0196 ID - Harrington2010 ER - TY - JOUR AU - Senzer, N. N. AU - Kaufman, H. L. AU - Amatruda, T. AU - Nemunaitis, M. AU - Reid, T. AU - Daniels, G. AU - Gonzalez, R. AU - Glaspy, J. AU - Whitman, E. AU - Harrington, K. PY - 2009 DA - 2009// TI - Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.24.3675 DO - 10.1200/JCO.2009.24.3675 ID - Senzer2009 ER - TY - JOUR AU - Geletneky, K. AU - Hajda, J. AU - Angelova, A. L. AU - Leuchs, B. AU - Capper, D. AU - Bartsch, A. J. AU - Neumann, J. O. AU - Schoning, T. AU - Husing, J. AU - Beelte, B. PY - 2017 DA - 2017// TI - Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial JO - Mol Ther VL - 25 UR - https://doi.org/10.1016/j.ymthe.2017.08.016 DO - 10.1016/j.ymthe.2017.08.016 ID - Geletneky2017 ER - TY - STD TI - Angelova AL, Barf M, Geletneky K, Unterberg A, Rommelaere J. Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity. Viruses. 2017;9:12. ID - ref215 ER - TY - JOUR AU - Hajda, J. AU - Lehmann, M. AU - Krebs, O. AU - Kieser, M. AU - Geletneky, K. AU - Jager, D. AU - Dahm, M. AU - Huber, B. AU - Schoning, T. AU - Sedlaczek, O. PY - 2017 DA - 2017// TI - A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3604-y DO - 10.1186/s12885-017-3604-y ID - Hajda2017 ER - TY - JOUR AU - Leuchs, B. AU - Frehtman, V. AU - Riese, M. AU - Muller, M. AU - Rommelaere, J. PY - 2017 DA - 2017// TI - A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles JO - Appl Microbiol Biotechnol VL - 101 UR - https://doi.org/10.1007/s00253-016-8071-x DO - 10.1007/s00253-016-8071-x ID - Leuchs2017 ER - TY - JOUR AU - Leuchs, B. AU - Roscher, M. AU - Muller, M. AU - Kurschner, K. AU - Rommelaere, J. PY - 2016 DA - 2016// TI - Standardized large-scale H-1PV production process with efficient quality and quantity monitoring JO - J Virol Methods VL - 229 UR - https://doi.org/10.1016/j.jviromet.2015.11.022 DO - 10.1016/j.jviromet.2015.11.022 ID - Leuchs2016 ER - TY - JOUR AU - Ungerechts, G. AU - Bossow, S. AU - Leuchs, B. AU - Holm, P. S. AU - Rommelaere, J. AU - Coffey, M. AU - Coffin, R. AU - Bell, J. AU - Nettelbeck, D. M. PY - 2016 DA - 2016// TI - Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses JO - Mol Ther Methods Clin Dev VL - 3 UR - https://doi.org/10.1038/mtm.2016.18 DO - 10.1038/mtm.2016.18 ID - Ungerechts2016 ER - TY - JOUR AU - Angelova, A. L. AU - Geletneky, K. AU - Nuesch, J. P. AU - Rommelaere, J. PY - 2015 DA - 2015// TI - Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients JO - Front Bioeng Biotechnol VL - 3 UR - https://doi.org/10.3389/fbioe.2015.00055 DO - 10.3389/fbioe.2015.00055 ID - Angelova2015 ER - TY - JOUR AU - Marchini, A. AU - Bonifati, S. AU - Scott, E. M. AU - Angelova, A. L. AU - Rommelaere, J. PY - 2015 DA - 2015// TI - Oncolytic parvoviruses: from basic virology to clinical applications JO - Virol J VL - 12 UR - https://doi.org/10.1186/s12985-014-0223-y DO - 10.1186/s12985-014-0223-y ID - Marchini2015 ER - TY - STD TI - Marr M, D'Abramo A, Pittman N, Agbandje-McKenna M, Cotmore SF, Tattersall P. Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene. Viruses. 2018;10 ID - ref222 ER - TY - JOUR AU - Kim, S. H. AU - Castro, F. AU - Paterson, Y. AU - Gravekamp, C. PY - 2009 DA - 2009// TI - High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action JO - Cancer Research VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4855 DO - 10.1158/0008-5472.CAN-08-4855 ID - Kim2009 ER - TY - JOUR AU - Kono, K. AU - Mimura, K. AU - Kiessling, R. PY - 2013 DA - 2013// TI - Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation JO - Cell death & disease VL - 4 UR - https://doi.org/10.1038/cddis.2013.207 DO - 10.1038/cddis.2013.207 ID - Kono2013 ER - TY - JOUR AU - Singh, M. AU - Quispe-Tintaya, W. AU - Chandra, D. AU - Jahangir, A. AU - Venkataswamy, M. M. AU - Ng, T. W. AU - Sharma-Kharkwal, S. AU - Carreno, L. J. AU - Porcelli, S. A. AU - Gravekamp, C. PY - 2014 DA - 2014// TI - Direct incorporation of the NKT-cell activator alpha-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy JO - Br J Cancer VL - 111 UR - https://doi.org/10.1038/bjc.2014.486 DO - 10.1038/bjc.2014.486 ID - Singh2014 ER - TY - JOUR AU - Shahabi, V. AU - Seavey, M. M. AU - Maciag, P. C. AU - Rivera, S. AU - Wallecha, A. PY - 2011 DA - 2011// TI - Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human JO - Cancer Gene Ther VL - 18 UR - https://doi.org/10.1038/cgt.2010.48 DO - 10.1038/cgt.2010.48 ID - Shahabi2011 ER - TY - JOUR AU - Staedtke, V. AU - Bai, R. Y. AU - Sun, W. AU - Huang, J. AU - Kibler, K. K. AU - Tyler, B. M. AU - Gallia, G. L. AU - Kinzler, K. AU - Vogelstein, B. AU - Zhou, S. AU - Riggins, G. J. PY - 2015 DA - 2015// TI - Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3627 DO - 10.18632/oncotarget.3627 ID - Staedtke2015 ER -